BROUSSARD BRUCE D
SEC insider (Form 3/4/5 filer). CIK 0001185643. Director at MARSH & MCLENNAN COMPANIES, INC. (MRSH) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 15, 2026. Located in NEW YORK, NY.
Companies BROUSSARD BRUCE D has filed insider reports for
- MARSH & MCLENNAN COMPANIES, INC. (MRSH): Director
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Director
- HP INC (HPQ): Director, Officer, Interim CEO
BROUSSARD BRUCE D
CIK: 0001185643
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)6 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 15, 2026MRSH
MARSH & MCLENNAN COMPANIES, INC.
AwardDirect192 shares at avg. $188.44$36K - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect3.8K shares- - Jun 1, 2026MRSH
MARSH & MCLENNAN COMPANIES, INC.
AwardDirect1.3K shares at avg. $159.28$215K - Feb 3, 2026HPQ
HP INC
AwardDirectRestricted Stock Units
344.1K shares- - Apr 14, 2025HPQ
HP INC
AwardDirect9.6K shares- - Apr 14, 2025HPQ
HP INC
AwardDirect4.8K shares at avg. $24.04$115K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 15, 2026 |  MRSH MARSH & MCLENNAN COMPANIES, INC. | Award | 192 | $188.44 | $36,181 | Direct |
| Jul 1, 2026 |  TAK TAKEDA PHARMACEUTICAL CO LTD | Award | 3,800 | - | $0 | Direct |
| Jun 1, 2026 | MRSH MARSH & MCLENNAN COMPANIES, INC. | Award | 1,349 | $159.28 | $214,869 | Direct |
| Feb 3, 2026 |  HPQ HP INC | Award Restricted Stock Units | 344,149 | - | - | Direct |
| Apr 14, 2025 | HPQ HP INC | Award | 9,568 | - | - | Direct |
| Apr 14, 2025 | HPQ HP INC | Award | 4,784 | $24.04 | $115,007 | Direct |
1-6 of 6 transactions